Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc |
Journal website http://www.jocmr.org |
Original Article
Volume 10, Number 3, March 2018, pages 189-195
Association of SIRT-1 Gene Polymorphism and Vitamin D Level in Egyptian Patients With Rheumatoid Arthritis
Tables
Variables | Rheumatoid cases (n = 50), mean ± SD | Controls (n = 20), mean ± SD | P-value |
---|---|---|---|
Independent t-test: Pearson χ2 (exact). SD: standard deviation. | |||
Sex | |||
Males | 38 (76%) | 9 (45%) | 0.023 |
Females | 12 (24%) | 11 (55%) | |
Age (years) | 40.1 ± 11.5 | 43.3 ± 9.8 | 0.289 |
Complete blood count | |||
RBCs (g/dL) | 92.4 ± 26.6 | 100.7 ± 16.5 | 0.199 |
Hb (g/dL) | 13.4 ± 1.9 | 13.8 ± 1.7 | 0.429 |
TLC (10/mm) | 6.6 ± 2 | 5.7 ± 0.98 | 0.047 |
PLT (10/mm) | 272.9 ± 94.7 | 239.1 ± 68.6 | 0.150 |
Liver function | |||
ALT (IU/L) | 44.6 ± 13.6 | 32.5 ± 5.7 | 0.000 |
AST (IU/L) | 52.6 ± 10.1 | 30.9 ± 5.5 | 0.000 |
Total bilirubin (mg/dL) | 0.72 ± 0.17 | 0.85 ± 0.23 | 0.036 |
Direct bilirubin (mg/dL) | 0.22 ± 0.10 | 0.23 ± 0.11 | 0.851 |
Albumin (g/dL) | 4.1 ± 0.48 | 4.3 ± 0.41 | 0.058 |
Other investigations | |||
Alkaline phosphatase (IU/L) | 67.2 ± 26 | 71.4 ± 23 | 0.536 |
Creatinine (mg/dL) | 0.91 ± 0.29 | 0.95 ± 0.18 | 0.02 |
CRP (mg/L) | 0.24 ± 0.13 | 0.23 ± 0.09 | 0.707 |
INR | 1.07 ± 0.10 | 1.12 ± 0.13 | 0.143 |
Anti-CCP (U/ML) | 61.7 ± 26 | 6.9 ± 4.5 | 0.000 |
TSH (mIU/L) | 1.7 ± 0.99 | 1.7 ± 0.77 | 0.799 |
AFP (ng/mL) | 2.9 ± 2.1 | 1.7 ± 0 | 0.012 |
Vit D (ng/mL) | 17.9 ± 9.2 | 42.2 ± 11.8 | 0.000 |
Variables | Rheumatoid cases (n = 50) | Controls (n = 20) | P-value | ||
---|---|---|---|---|---|
No. | % | No. | % | ||
ANA titer | |||||
Low titer | 50 | 100% | 20 | 100% | - |
Vitamin D level | 0.000 | ||||
Deficient (< 10 ng/mL) | 3 | 6% | 0 | 0% | |
Insufficient (10 - 29 ng/mL) | 44 | 88% | 0 | 0% | |
Sufficient (30 - 100 ng/mL) | 3 | 6% | 20 | 100% |
Variables | Rheumatoid cases (n = 50) | Controls (n = 20) | P-value | ||
---|---|---|---|---|---|
No. | % | No. | % | ||
rs2273773 C>T | |||||
CC | 18 | 36% | 12 | 60% | |
CT | 19 | 38% | 8 | 40% | 0.000 |
TT | 13 | 26% | 0 | 0% | |
Allele | |||||
C | 55 | 55% | 32 | 80% | 0.006 |
T | 45 | 45% | 8 | 20% | |
rs7895833 A>G | |||||
GG | 27 | 54% | 2 | 10% | |
AG | 17 | 34% | 6 | 30% | 0.000 |
AA | 6 | 12% | 12 | 60% | |
Allele | |||||
G | 71 | 71% | 10 | 25% | < 0.001 |
A | 29 | 29% | 30 | 75% | |
rs7069102 C>G | |||||
GG | 31 | 62% | 0 | 0% | |
CG | 13 | 26% | 5 | 25% | 0.000 |
CC | 6 | 12% | 15 | 75% | |
Allele | |||||
C | 25 | 25% | 35 | 87.5% | < 0.001 |
G | 75 | 75% | 5 | 12.5% |
Variables | Vitamin D | P-value | |
---|---|---|---|
Mean | SD | ||
rs2273773 | |||
TT | 17.3 | 9.5 | |
TC | 16.3 | 4.7 | 0.4 |
CC | 20.9 | 13.1 | |
rs7895833 | |||
GG | 17.4 | 6.1 | |
AG | 19.9 | 13.5 | 0.4 |
AA | 13.9 | 4.6 | |
rs7069102 | |||
GG | 15.9 | 4.5 | |
CG | 22.1 | 15.7 | 0.2 |
CC | 16.5 | 5.2 |
Variables | Anti-CCP | P-value | |
---|---|---|---|
Mean | SD | ||
rs2273773 | |||
TT | 59.6 | 23.4 | |
TC | 59.1 | 17.4 | 0.6 |
CC | 68.5 | 38.3 | |
rs7895833 | |||
GG | 67.9 | 29.9 | |
AG | 58.9 | 18.6 | 0.07 |
AA | 41.8 | 13 | |
rs7069102 | |||
GG | 58.2 | 23.1 | |
CG | 71.7 | 39 | 0.3 |
CC | 58.2 | 18.7 |
Variables | Vitamin D | |
---|---|---|
r | P-value | |
Age (years) | 0.19 | 0.2 |
Complete blood count | ||
RBCs | 0.15 | 0.3 |
Hb | -0.11 | 0.5 |
TLC | 0.09 | 0.5 |
PLT | 0.02 | 0.9 |
Liver function | ||
ALT | -0.16 | 0.3 |
AST | 0.04 | 0.8 |
Total bilirubin | 0.27 | 0.09 |
Direct bilirubin | 0.25 | 0.08 |
Albumin | -0.26 | 0.07 |
Other routine investigations | ||
Alkaline phosphatase | 0.07 | 0.6 |
Creatinine | -0.19 | 0.2 |
PC | 0.04 | 0.8 |
CRP | -0.06 | 0.6 |
INR | 0.14 | 0.3 |
Other | ||
Anti-CCP | 0.14 | 0.4 |
TSH | -0.16 | 0.3 |
AFP | -0.19 | 0.2 |